Research Products and Multi-Vial Collections
Research Summary
Ipamorelin / CJC-1295 is a dual-peptide research formulation combining two compounds studied for their interaction with growth hormone regulatory signaling pathways.
Research investigations commonly evaluate:
- Growth hormone releasing hormone (GHRH) signaling pathways
- Ghrelin receptor interaction and peptide signaling
- Hypothalamic-pituitary endocrine communication
- Neuroendocrine regulatory pathways
- Hormonal feedback loop mechanisms
By combining two complementary peptide signaling pathways, Ipamorelin / CJC-1295 is frequently examined in laboratory models studying integrated endocrine signaling systems and growth hormone regulatory networks.
Available Vial Options
10mg Lyophilized Peptide Blend
- Ipamorelin – 5mg
- CJC-1295 – 5mg
All vials meet ≥99% purity standards and undergo third-party analytical verification.
Stack Composition
Technical Specifications
| Product Name | Ipamorelin / CJC-1295 |
| Functional Category | Growth hormone secretagogue peptide blend |
| Component Peptides: | Ipamorelin CJC-1295 |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Testing Location | Tested and verified in the USA |
| Testing | Third-party verified |
| Intended Use | Laboratory research only |
Research Compound Profile
| Attribute | Description |
|---|---|
| Compound Type | Peptide signaling blend |
| Molecular Class | Synthetic peptide analogs |
| Target Pathways | Growth hormone regulatory signaling |
| Research Category | Endocrine peptide signaling |
| Peptide Form | Lyophilized powder |
| Purity Verification | ≥99% via HPLC |
Mechanism of Action
In laboratory models, Ipamorelin and CJC-1295 are examined for their interaction with growth hormone regulatory signaling pathways within the hypothalamic–pituitary axis.
Ipamorelin is investigated as a ghrelin receptor agonist analog, studied for its interaction with ghrelin receptors involved in growth hormone signaling.
CJC-1295 is studied as a growth hormone releasing hormone (GHRH) analog, interacting with receptors associated with hypothalamic signaling pathways that influence endocrine hormone release.
Research investigations explore how these peptides may influence:
- Hypothalamic-pituitary endocrine signaling pathways
- Growth hormone regulatory feedback systems
- Neuroendocrine peptide communication networks
- Hormonal cascade signaling mechanisms
- Receptor-mediated peptide signaling
The combined peptide formulation allows researchers to examine multi-pathway endocrine signaling models involving both ghrelin receptor interaction and GHRH pathway modulation.
Areas of Scientific Investigation
Preclinical and mechanistic studies examining growth hormone secretagogue peptides frequently investigate:
- Hypothalamic-pituitary endocrine signaling
- Neuroendocrine regulatory pathways
- Hormone receptor interaction models
- Peptide-mediated endocrine communication
- Growth hormone regulatory signaling systems
All references reflect controlled laboratory research environments only and do not imply therapeutic application.
Storage & Handling
- Store lyophilized peptide at 2–8°C
- Protect from light and moisture
- Maintain sterile laboratory handling conditions
- Reconstituted materials should be managed according to research protocol standards
Quality & Verification
PeptideBlend research peptides are:
- Tested and verified in the United States
- Produced under controlled laboratory conditions
- Third-party tested for identity and purity
- Verified at ≥99% purity via HPLC analysis
Certificates of Analysis (COA) available upon request.
Frequently Asked Questions
What is Ipamorelin / CJC-1295?
Ipamorelin / CJC-1295 is a peptide blend studied in laboratory research environments for its interaction with growth hormone regulatory signaling pathways.
What pathways are investigated with Ipamorelin / CJC-1295?
Research models commonly examine:
- Growth hormone releasing hormone signaling
- Ghrelin receptor peptide signaling
- Hypothalamic-pituitary endocrine communication
What form is Ipamorelin / CJC-1295 supplied in?
Ipamorelin / CJC-1295 is supplied as a lyophilized peptide powder requiring laboratory reconstitution.
Is Ipamorelin / CJC-1295 intended for human use?
No. This compound is supplied strictly for laboratory research and analytical purposes.
Scientific Literature Context
Scientific literature examining growth hormone secretagogue peptides frequently investigates interactions between ghrelin receptor signaling and growth hormone releasing hormone pathways within neuroendocrine systems.
These studies provide foundational insight into peptide-mediated endocrine signaling mechanisms studied in controlled laboratory environments.
Research Use Disclaimer
This product is intended strictly for laboratory research and analytical purposes only.
Not for human consumption.
Not for diagnostic, therapeutic, or veterinary use.
PeptideBlend does not market or sell products for medical or pharmaceutical application.